Drug Approved to Fight Rare Cancer That Hits Young Adults
WEDNESDAY, Aug. 7, 2024 (HealthDay News) — A new immunotherapy is now available to treat a rare soft tissue cancer that most frequently occurs in young men. The U.S. Food and Drug Administration has granted accelerated approval to Tecelra (afamitresgene autoleuecel) to treat synovial sarcoma, which most commonly develops inContinue Reading